Related Experiment Videos
Editorial: the current status of feline leukemia virus research
Clinical Bulletin
|January 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.
Cell death and differentiation·2009
IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
Annals of the New York Academy of Sciences·2007
Neuroendocrine immune interactions in health and disease.
International immunopharmacology·2003
A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma.
International immunopharmacology·2002
Immunomodulatory properties of Mycoplasma pulmonis. I. Characterization of the immunomodulatory activity.
International immunopharmacology·2001
Immunomodulatory properties of Mycoplasma pulmonis. III. Lymphocyte stimulation and cytokine production by Mycoplasma pulmonis products.
International immunopharmacology·2001
Patients who seek unproven cancer remedies: a psychological perspective.
Clinical bulletin·1981
Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
Clinical bulletin·1981
Multiparameter flow cytometry. Part II. application in hematology.
Clinical bulletin·1981
Sclareol Inhibit Cell Growth and Induces Apoptosis via Activation of p53/p21 Signaling Pathways in Human Oral Squamous Cell Carcinoma Cells.
Journal of biochemical and molecular toxicology·2026
ARID1A Mediates ROS-Induced Osteoclast Activation in TMJ Osteoarthritis.
Journal of dental research·2026